A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Clinical trial NCT03697109 · COMPLETED
Trial details
- NCT number
- NCT03697109
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2024-04-08
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.